Edge Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 10

Edge Therapeutics General Information

Description

Edge Therapeutics Inc operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. Its core objective lies in the development and commercialization of therapies for serious unmet medical conditions, especially neurological disorders in the hospital setting. The company is currently evaluating EG-1962, its lead product candidate, in the Phase 3 NEWTON 2 study in adult patients with aneurysmal subarachnoid hemorrhage (aSAH). Edge uses its trademark platform known as Precisa, which enables the creation of polymer-based therapeutics capable of delivering directly to the site of injury, without affecting other areas of the body resulting in side-effects.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Primary Office
  • 300 Connell Drive
  • Suite 4000
  • Berkeley Heights, NJ 07922
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Edge Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edge Therapeutics‘s full profile, request access.

Request a free trial

Edge Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Edge Therapeutics Inc operates as a clinical stage biotechnology company, principally involved in drug discovery in the
Other Healthcare Technology Systems
Berkeley Heights, NJ
00000
00.00 0000-00-00
000000&0 00000

0000 000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000 000000000
Palo Alto, CA
00 As of 0000
000.00
000000000 - 000.00

00000000

n reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
0000 000000000
San Diego, CA
000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edge Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aria Pharmaceuticals Venture Capital-Backed Palo Alto, CA 00 000.00 000000000 - 000.00
000000000 00000000 Private Equity-Backed San Diego, CA 000 00000 0000000 0000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Edge Therapeutics Patents

Edge Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180098977-A1 Scalable microparticulate formulations containing polymorphic nimodipine form 2 prepared by a solvent evaporation process Abandoned 23-Aug-2016 00000000000
US-20180055813-A1 Compositions and methods for treating atrial fibrillation Abandoned 18-May-2016 0000000000
US-20190054022-A1 Formulations of site-specific, microparticulate compositions and their use to improve outcome after aneursymal subarachnoid hemorrhage Abandoned 07-Apr-2016 0000000000
AU-2016271152-A1 Compositions and methods for reducing visual loss Abandoned 29-May-2015 0000000000
GB-201721810-D0 Compositions and methods for reducing visual loss Pending 29-May-2015 A61K9/0048
To view Edge Therapeutics’s complete patent history, request access »

Edge Therapeutics Executive Team (17)

Name Title Board Seat Contact Info
Brian Leuthner Chief Executive Officer, President & Director
Daniel Brennan Chief Operating Officer
R. Loch Macdonald Ph.D Chief Scientific Officer & Director
Carl Soranno JD Co-Founder & Corporate Secretary
Som Leung Ph.D Director, Program Management
You’re viewing 5 of 17 executive team members. Get the full list »

Edge Therapeutics Board Members (9)

Name Representing Role Since
00000 00000 Self Vice Chairman of the Board of Director 000 0000
00000 00000 Self Vice Chairman 000 0000
00000 00000000 Edge Therapeutics Board Member 000 0000
000000 0000000 00 Self Board Member 000 0000
000 00000 00.0 Self Chairman of the Board 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Edge Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Edge Therapeutics‘s full profile, request access.

Request a free trial